全球乙胺嘧啶市场 – 行业趋势及 2029 年预测

乙胺嘧啶市场分析及规模

乙胺嘧啶被世界卫生组织列为基本药物，是最重要的药物之一。乙胺嘧啶能够治愈原虫感染和弓形虫感染，全球 HIV 阳性患者数量不断增加，免疫抑制患者面临感染风险，这些是预测期内推动乙胺嘧啶治疗市场发展的主要因素。

Data Bridge Market Research 分析了 2022-2029 年预测期内全球乙胺嘧啶市场的增长率。在上述预测期内，全球乙胺嘧啶市场的预期复合年增长率趋于 5.50% 左右。2021 年市场价值为 15.1 亿美元，到 2029 年将增长至 23.2 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

乙胺嘧啶市场范围和细分

市场定义

Pyrimethamine is one of the antagonists of folic acid that is used as an antimalarial or with a sulphonamide to treat toxoplasmosis. Pyrimethamine impedes plasmodia dihydrofolate reductase as it blocks the biosynthesis of purines and pyrimidines, that are essential for DNA synthesis and cell multiplication. This process leads to failure of nuclear division at the time of schizont formation in erythrocytes and liver. It is usually used as an adjunct in the treatment of uncomplicated, chloroquine resistant, P. falciparum malaria.  

Global Pyrimethamine Market Dynamics

Drivers

• Increase in HIV cases

As per the global HIV statistics published by The Joint United Nations Programme on HIV/AIDS, in 2020, worldwide, there were 37.7 million people living with HIV, out of which 36.0 million were adults, 1.7 million were children aged between 0-14 years, and 53% of all people living with HIV were women and girls. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is projected to boost the market growth. The segment is anticipated to accelerate the global market as most products are available in capsule and tablet form and it is a very convenient route of administration.

Opportunities

• Increasing Drug Development and Research Activities

Technological advancements and rapid innovation in drug discovery and development, especially in personalized medicine, create significant opportunities for manufacturers in the global pyrimethamine market. This is another factor expected to drive growth of the global pyrimethamine market.  

• Increasing Cases of Toxoplasmosis

According to The Centers for Disease Control and Prevention (CDC), toxoplasmosis is one of the five neglected parasitic infections in the U.S. It is the second leading cause of death from foodborne illness in the country and more than 60 million people in the U.S. carry the toxoplasma parasite, and more than one million people in the U.S. are infected yearly with the toxoplasma parasite, that is associated with high rates of morbidity and mortality.

 Restraints/Challenges

• Side Effects of Aminophylline

The certain side effects which may occur with pyrimethamine medication include allergic reactions, tongue changes, blood in the urine, heart rhythm disorders, blood disorders, anorexia, and vomiting that act as a restraining factor for the growth of this market.

• High Cost

The huge expenditure associated with these agents hamper the market growth.

This global pyrimethamine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pyrimethamine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Pyrimethamine Market             

COVID-19 has left a major global public health crisis that has impacted practically every sector, and its long-term consequences are expected to have an influence on industry growth during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and much delays in clinical trials.

In the post-pandemic era, the biotechnology and pharmaceutical industries are projected to witness a huge future growth because of the demand for vaccine and treatment drugs for COVID-19. Thus, this will leave a significant impact on the global pyrimethamine market.

Global Pyrimethamine Market Scope

The global pyrimethamine market is segmented on the basis of indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indications

• Malaria
• Toxoplasmosis
• Others

Route of Administration

• Oral

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Pyrimethamine Market Regional Analysis/Insights

The global pyrimethamine market is analyzed and market size insights and trends are provided by indication, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global pyrimethamine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

由于政府宣传活动的加强以及疟疾和艾滋病患病率的上升，在预测期内，亚太地区的全球乙胺嘧啶市场一直呈现积极增长。  

北美由于其产品的关键制造、高水平的研发、医疗保健支出和熟练的专业人员的存在而占据市场主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球乙胺嘧啶市场份额分析

全球乙胺嘧啶市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球乙胺嘧啶市场的关注有关

全球乙胺嘧啶市场的主要参与者包括：

• 拜耳公司（德国）
• Teva Pharmaceutical Industries Ltd.（以色列）
• 太阳制药工业有限公司 (印度)
• Hikma Pharmaceutical PLC（英国）
• Amneal Pharmaceuticals LLC.（英国）
• Aurobindo Pharma（印度）
• Vyera Pharmaceuticals, LLC（瑞士）
• CEROVENE INC HEALTHCARE PVT.LTD（印度）
• Amneal Pharmaceuticals LLC（美国）
• PRN（美国）
• TargetMol Chemicals Inc.（美国）

SKU-55259